TickerFactsScreenerDevelopers

Matinas BioPharma Holdings, Inc. (MTNB) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2012: -$116.6K2013: $10.47M2014: $2.23M2015: $6.07M2016: $7.15M2017: $10.68M2018: $16.14M2019: $33.05M2020: $63.73M2021: $52.49M2022: $36.64M2023: $19.25M2024: $7.59M2025: $4.83M$4.83M
2012Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$4.83M-36.4%
2024$7.59M-60.6%
2023$19.25M-47.5%
2022$36.64M-30.2%
2021$52.49M-17.6%
2020$63.73M+92.8%
2019$33.05M+104.8%
2018$16.14M+51.1%
2017$10.68M+49.4%
2016$7.15M+17.7%
2015$6.07M+172.6%
2014$2.23M-78.7%
2013$10.47M+9084.1%
2012-$116.6K—